Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices.

Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint in Europe.

Read full article from Mass Device here. 

Did you miss our series of live webinars? Learn how doctors around the world use Simbionix simulators in their programs by watching the recordings here: https://t.co/StQ5uIvvGp
#Simbionix #simulation #medicalsimulation #MedEd #medicaleducation

Breaking - A study presented at #HRS2021 concluded that the human review of ambulatory ECG recordings outperformed computer algorithm-dependent MCT: https://t.co/L9UjWHl7aG
#cardiology #CardioTwitter #EPeeps #ECG #afib

#Cardiovascular health is important for women at any stage of life. A recent study published in the @American_Heart Stroke Journal found that women who hit menopause before 40 had a risk of ischemic #stroke 1.5x higher than those ages 50-54: https://t.co/cat8nImRTq #CardioTwitter